Medincell

Medincell is a clinical- and commercial-stage biopharmaceutical licensing company developing long-acting injectable drugs. Their innovative treatments aim to improve medicine effectiveness and accessibility while reducing environmental impact, using their proprietary BEPO® technology. The company collaborates with pharmaceutical companies and foundations to improve global health.

Buy Funded Startups lists

Funding Round: Grant

Funding Amount: $6M

Date: 08-Apr-2024

Investors: Unitaid

Markets: Biopharmaceutical, Pharmaceuticals, Drug Discovery, Biotechnology

HQ: Jacou, Occitanie, France

Founded: 2002

Website: https://www.medincell.com

LinkedIn: https://www.linkedin.com/company/medincell/

Twitter: https://twitter.com/medincell

Instagram: